Implementation of dosimetry for molecular radiotherapy; results from a European survey

Treatments with radioactive nuclides, also known as molecular radiotherapies (MRTs), have been rapidly increasing over the last years. The aim is to deliver an absorbed dose to the region of disease, leading to a therapeutic effect, while minimising absorbed doses to non-target tissues. While some treatments, including radioactive iodine (Na[131I]I), have been in routine use since the 1940s [1,2], many new carriers and radionuclides have been developed for MRTs in the last decade. A recent review found that 72 radionuclides have been investigated for molecular radiotherapy [3].
Source: Physica Medica: European Journal of Medical Physics - Category: General Medicine Authors: Tags: Original paper Source Type: research